Skip Navigation

Our Testicular Cancer Team

Urology

Photo of Dr. Mohamad Ezzeddine Allaf, M.D.

Allaf, Mohamad Ezzeddine, M.D.

Professor of Urology
Associate Professor of Biomedical Engineering
Professor of Oncology
Executive Vice Chairman, Department of Urology
Director of Adult Urology
Director, Minimally Invasive and Robotic Surgery
Expertise, Disease and Conditions: Kidney Cancer, Laparoscopic Kidney Surgery, Prostate Cancer, Robotic Prostatectomy, Urology
 
Photo of Dr. Trinity Jude Bivalacqua, M.D., Ph.D.

Bivalacqua, Trinity Jude, M.D., Ph.D.

Associate Professor of Urology
Associate Professor of Oncology
Associate Professor of Surgery
Director of Urologic Oncology
Deputy Director, Johns Hopkins Greenberg Bladder Cancer Institute
Expertise, Disease and Conditions: Bladder Cancer, Erectile Dysfunction, Genitourinary Sarcoma, Penile Cancer, Prostate Cancer, Robotic Prostatectomy, Urethral Cancer, Urinary Tract Cancer, Urological Oncology, Urology
 
Photo of Dr. Heather Noelle Di Carlo, M.D.

Di Carlo, Heather Noelle, M.D.

Assistant Professor of Urology
Director, Pediatric Urology Research
Expertise, Disease and Conditions: Bladder Cancer, Bladder Exstrophy, Hernias, Hypospadias, Kidney Cancer, Pediatric Urology, Prostate Cancer, Undescended Testis, Urology, Vesicoureteral Reflux
 
Photo of Dr. Michael Hiroshi Johnson, M.D.

Johnson, Michael Hiroshi, M.D.

Assistant Professor of Urology
Associate Program Director Urologic Oncology Fellowship
Director, International Urology
Expertise, Disease and Conditions: Bladder Cancer, Kidney Cancer, Prostate Cancer, Urology
 
Photo of Dr. Max Reuben Kates, M.D.

Kates, Max Reuben, M.D.

Assistant Professor of Urology
Assistant Professor of Oncology
Co-Director, Bladder Cancer Multidisciplinary Clinic
Expertise, Disease and Conditions: Benign Prostatic Hyperplasia (BPH), Bladder Cancer, Kidney Cancer, Penile Cancer, Prostate Cancer, Robotic Cystectomy, Robotic Nephrectomy, Robotic Partial Nephrectomy, Robotic Prostatectomy, Robotic Surgery, Testicular Cancer
 
Photo of Dr. Phillip Martin Pierorazio, M.D.

Pierorazio, Phillip Martin, M.D.

Associate Professor of Urology
Associate Professor of Oncology
Director, Division of Testis Cancer
Director of Social Media
Expertise, Disease and Conditions: Active Surveillance for Kidney Cancer, Active Surveillance of Prostate Cancer, Adrenal Surgery, Adrenalectomy, Bladder Cancer, Genitourinary Sarcoma, Kidney Cancer, Laparoscopic Adrenalectomy, Laparoscopic Nephrectomy, Nephron Sparing Surgery, Nephroureterectomy, Open Partial Nephrectomy, Partial Nephrectomy, Partial Orchiectomy, Prostate Cancer, Radical Orchiectomy, Retroperitoneal Lymph Node Dissection, Robotic Adrenalectomy, Robotic and Laparoscopic Surgery, Robotic Partial Nephrectomy, Robotic Prostatectomy, Robotic RPLND, Testicular Cancer, Testis Sparing Surgery, Transurethral Resection of Bladder Tumor, Upper Tract Urothelial Cancer, Urologic Surgery, Urology, Von Hippel-Lindau (VHL)
 
Photo of Dr. Armine K. Smith, M.D.

Smith, Armine K., M.D.

Assistant Professor of Urology
Director, Johns Hopkins Urologic Oncology at Sibley Memorial Hospital
Expertise, Disease and Conditions: Bladder Cancer, Kidney Cancer, Laparoscopic Kidney Surgery, Laparoscopic Nephrectomy, Minimally Invasive Surgery, Penile Cancer, Prostate Cancer, Robotic Prostatectomy, Robotic Surgery, Testicular Cancer, Ureteropelvic Junction Obstruction, Urethral Cancer, Urologic Surgery, Urological Oncology, Urology
 

Medical Oncology

Photo of Dr. Noah Matthew Hahn, M.D.

Hahn, Noah Matthew, M.D.

Associate Professor of Oncology
Associate Professor of Urology
Deputy Director, Johns Hopkins Greenberg Bladder Cancer Institute
Expertise, Disease and Conditions: Bladder Cancer, Medical Oncology
 

TESTICULAR CANCER GO-TEAM

MISSION STATEMENT

To treat any patient with testicular cancer who presents or wishes to be seen at Johns Hopkins in a timely fashion.

Treatment can include any stage of disease from the clinically localized, early-stage patient to locally advanced and/or metastatic disease.  Treatment includes management of oncologic issues and consideration of fertility, quality-of-life and survivorship. A timely fashion implies that all involved team members pledge to have each patient initiate treatment within two weeks of presentation

The process will involve review of the case by the "triage team" who determine primary service (urology or medical oncology), the subsequent care needed, contact necessary members of the team and facilitate initiation of treatment. The triage team will then contact members of the adjunct services only as needed.

To be properly evaluated by the GO-TEAM, a patient should have:

  • Imaging (scrotal ultrasound preferable) demonstrating a solid, vascular mass of the testicle.
  • Tumor marker blood tests (HCG, AFP, LDH)

OR

  • A history of testicular cancer with radiographic or serum evidence of recurrence.

UROLOGY 
Phillip M. Pierorazio, MD*  
Mohamad E. Allaf, MD 
Trinity Jude Bivalacqua, M.D., Ph.D.
Michael H. Johnson, MD
Armine K. Smith, MD

PEDIATRIC UROLOGY
Heather DiCarlo, MD

MEDICAL ONCOLOGY
Noah Hahn, MD*
Channing Paller, MD

PEDIATRIC MEDICAL ONCOLOGY
Alan Friedman, MD*

TEAM COORDINATOR
Heather Gausepohl, NP* 

NEUROLOGY & NEUROSURGERY      
Wolinsky, Jean-Paul, M.D.

VASCULAR SURGERY
James Black, MD                 
Ying-Wei Lum, MD    

GENERAL SURGERY
Christopher Wolfgang, MD, PhD  
Matthew Weiss, MD      

CARDIAC & THORACIC SURGERY
Steven Yang, MD                            

HEAD & NECK SURGERY
Carol Fakhry, MD   

PATHOLOGY
Jonathan I Epstein, M.D.
Andres Matoso, M.D.

OPERATING ROOM COORDINATION & SUPPORT
Jackie L. Martin, MD          

SURVIVORSHIP
Christina Miller, MS, LCPC - The Ulman Cancer Fund for Young Adults

*Triage Team
For an assessment by the GOTEAM, please call Dr.Pierorazio or Heather Gausepohl at 410 502 5984.

back to top button